Clinical Trials Directory

Trials / Completed

CompletedNCT03436082

Post-Market Surveillance With a Novel mHealth Platform

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation

Detailed description

The plan is to pilot test a novel patient-led, smartphone-based mobile health platform (called Hugo) for real-world surveillance of outcomes in 60 total patients after medical device use. Research associates will be recruiting patients before they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation. Patients will then be queried about specific symptoms related to their procedure. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes. This pilot project will engage patients to report outcomes while also synchronizing data from their electronic health records and pharmacy accounts to ascertain the ability of emerging mobile health technologies to aid in post-marketing surveillance.

Conditions

Interventions

TypeNameDescription
DEVICEA mobile health platformPatients pilot testing the smartphone based, mobile health platform called HUGO. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes.Patients will be queried about specific symptoms related to their procedure at enrollment, one week post-procedure, at 4 weeks and again at 8 weeks.

Timeline

Start date
2018-01-26
Primary completion
2018-12-25
Completion
2018-12-25
First posted
2018-02-19
Last updated
2021-03-19
Results posted
2021-03-19

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03436082. Inclusion in this directory is not an endorsement.

Post-Market Surveillance With a Novel mHealth Platform (NCT03436082) · Clinical Trials Directory